A citation-based method for searching scientific literature

Yang Liu, Stefan Klaus Barta. Am J Hematol 2019
Times Cited: 157



Bruce D Cheson, Richard I Fisher, Sally F Barrington, Franco Cavalli, Lawrence H Schwartz, Emanuele Zucca, T Andrew Lister. J Clin Oncol 2014
Times Cited: 2212




List of shared articles



Times cited

Outcomes of HTLV-1 Carriers with Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Matched Cohort Study.
Bryan Valcarcel, Gustavo Sandival Ampuero, Gabriel de la Cruz-Ku, Daniel J Enriquez, Luis Malpica. Clin Lymphoma Myeloma Leuk 2022
0

Integration of Baseline Metabolic Parameters and Mutational Profiles Predicts Long-Term Response to First-Line Therapy in DLBCL Patients: A Post Hoc Analysis of the SAKK38/07 Study.
Sofia Genta, Guido Ghilardi, Luciano Cascione, Darius Juskevicius, Alexandar Tzankov, Sämi Schär, Lisa Milan, Maria Cristina Pirosa, Fabiana Esposito, Teresa Ruberto,[...]. Cancers (Basel) 2022
0

Evolution of therapy for limited stage diffuse large B-cell lymphoma.
Alexandra E Rojek, Sonali M Smith. Blood Cancer J 2022
0


Clinical Features and Immunophenotypes of Double-Hit Diffuse Large B-Cell Lymphoma.
Cheng-Han Wu, Jyh-Pyng Gau, Chieh-Lin Jerry Teng, Yu-Hsuan Shih, Yu-Chen Su, Ren-Ching Wang, Tsung-Chih Chen. Diagnostics (Basel) 2022
0

Repeat biopsy in relapsed or refractory diffuse large B cell lymphoma: a nationwide survey and retrospective study.
Tamar Berger, Karyn Revital Geiger, Moshe Yeshurun, Anat Gafter-Gvili, Tzippy Shochat, Ronit Gurion, Pia Raanani, Oren Pasvolsky. Leuk Lymphoma 2022
0

Spatial signatures identify immune escape via PD-1 as a defining feature of T-cell/histiocyte-rich large B-cell lymphoma.
Gabriel K Griffin, Jason L Weirather, Margaretha G M Roemer, Mikel Lipschitz, Alyssa Kelley, Pei-Hsuan Chen, Daniel Gusenleitner, Erin Jeter, Christine Pak, Evisa Gjini,[...]. Blood 2021
9

Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma.
Jatin Shah, Sharon Shacham, Michael Kauffman, Patrick Daniele, Dimitrios Tomaras, Gabriel Tremblay, Rene-Olivier Casasnovas, Marie Maerevoet, Josee Zijlstra, George Follows,[...]. Future Oncol 2021
1

Clinical, inflammatory and immunohistochemical features in a cohort of Peruvian patients with diffuse large B-cell lymphoma.
Denisse Castro, Brady Beltrán, María Del Pilar Quiñones, Carlos Pachas, Yesenia Huerta, Karen Lalupu, Ronald Mendoza, Jorge J Castillo. Leuk Res 2021
1

Evaluation of the prognostic utility of bone marrow biopsy in diffuse large B-Cell lymphoma in the SEER-Medicare dataset.
Danny Luan, Yiyuan Wu, Jordan Goldstein, Sarah Rutherford, John P Leonard, Peter Martin. Leuk Lymphoma 2021
0

[The prognostic impact of diabetic mellitus and hyperglycemia during DLBCL treatment on patients with diffuse large B-cell lymphoma].
Y Hu, Y J Xu, M Z Li, Y X Lan, L Mao, Q Y Ning, W Xu, H L Yang, Y Z Zhang. Zhonghua Xue Ye Xue Za Zhi 2021
1

Angiogenesis' related genetic variants alter clinical features and prognosis of diffuse large B-cell lymphoma patients.
Angelo Borsarelli Carvalho Brito, Marcia Torresan Delamain, Marcello Ferreti Fanelli, Fernando Augusto Soares, Cármino Antônio de Souza, José Vassallo, Carmen Silvia Passos Lima. Tumour Biol 2021
0

Pyruvate dehydrogenase kinase 4-mediated metabolic reprogramming is involved in rituximab resistance in diffuse large B-cell lymphoma by affecting the expression of MS4A1/CD20.
Duanfeng Jiang, Qiuyu Mo, Xiaoying Sun, Xiaotao Wang, Min Dong, Guozhen Zhang, Fangping Chen, Qiangqiang Zhao. Cancer Sci 2021
2

The Role of Interim PET/CT on Survival in Diffuse Large B Cell Lymphoma.
Meral Uluköylü Mengüç, Özgür Mehtap, Gözde Dağlıöz Görür, Elif Birtaş Ateşoğlu, Ayfer Gedük, Serkan Ünal, Pınar Tarkun, Abdullah Hacıhanefioğlu. Clin Lymphoma Myeloma Leuk 2021
0